Gefitinib - Api
Gefitinib is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR.
Pharmacopoeia: IP/BP
CAS ID: 184475-35-2
Formula: C22H24ClFN4O3
ChemSpiderID: 110217